Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mark, Shlomchik"'
205 Local tissue microenvironment regulates T cell phenotypes in murine systemic lupus erythematosus
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/f9bb868c59a74a9bae4e065126eb93ce
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/2f17a9409495484f8caa079ab43fba3e
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d62859edbc074d408d382e9ba1260a81
Publikováno v:
Lupus Nephritis.
Publikováno v:
Bio-Protocol, Vol 5, Iss 16 (2015)
The adoptive transfer of antigen-specific B cells into mice that cannot recognize that specific antigen has two main advantages. The first is determining exactly when the B cells were transferred and exposed to antigen. The second is that all B cells
Externí odkaz:
https://doaj.org/article/91f90306d1a8412cbdbbcd629ddcd30d
Publikováno v:
Cancer Research. 82:2831-2831
Adoptive T cell therapy with CD8+ T cells engineered to express T cell receptors (TCRs) that recognize hematopoietically-restricted minor histocompatibility antigens (miHAs) is an attractive approach for improving the efficacy of allogeneic hematopoi
Autor:
Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17103 (2011)
Recent clinical trials have established B cell depletion by the anti-CD20 chimeric antibody Rituximab as a beneficial therapy for patients with relapsing-remitting multiple sclerosis (MS). The impact of Rituximab on T cell responses remains largely u
Externí odkaz:
https://doaj.org/article/7eb457a109ad42ca8f3e5a28c0d1260d
Autor:
Bianka Marklein, Madeleine Jenning, Karen Münzner, Zoltan Konthur, Thomas Häupl, Andrew Cope, Mark Shlomchik, Hans-J Anders, Günter Steiner, Gerd R Burmester, Karl Skriner
Publikováno v:
New players and novel targets in inflammation.
Autor:
Ronald, Herbst, Yue, Wang, Sandra, Gallagher, Nanette, Mittereder, Ellen, Kuta, Melissa, Damschroder, Rob, Woods, Daniel C, Rowe, Li, Cheng, Kim, Cook, Krista, Evans, Gary P, Sims, David S, Pfarr, Michael A, Bowen, William, Dall'Acqua, William, Dall'Aqua, Mark, Shlomchik, Thomas F, Tedder, Peter, Kiener, Bahija, Jallal, Herren, Wu, Anthony J, Coyle
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 335:213-222
The pan B-cell surface antigen CD19 is an attractive target for therapeutic monoclonal antibody (mAb) approaches. We have generated a new afucosylated anti-human (hu)CD19 mAb, MEDI-551, with increased affinity to human FcγRIIIA and mouse FcγRIV and
Autor:
Kazuhiko Yamamoto, Mark Shlomchik
Publikováno v:
Current opinion in immunology. 22(6)